Andrew King
PCR Corp · University of Manchester · King-Maceyko Dermatology Associates
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew King as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:37 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04512274 · Skin Protectant Properties of Omeza Collagen Matrix on Damaged SkinOmeza, LLC · completed · Transepidermal Water Loss, Erythema · study director
- Ph3NCT03249207 · SC IL-1Ra in SAH - Phase III Trial (SCIL)University of Manchester · unknown · Subarachnoid Hemorrhage · principal investigator
- Ph3NCT01188928 · LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)LEO Pharma · completed · Psoriasis Vulgaris · principal investigator
- N/ANCT01019109 · Scoliosis Surgery Using the PASS® LP SystemMedicrea, USA Corp. · completed · Idiopathic Scoliosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:37 UTC. The ranking covers the 200 most relevant of 453 PubMed records, and a shared surname and initials can bring in a namesake. All 453 on PubMed
- 1,132 citationsRCR 45.9
- Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.Ann Intern Med · 19951,080 citationsRCR 33.0
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.N Engl J Med · 2021788 citationsRCR 47.4
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.N Engl J Med · 2021753 citationsRCR 43.8
- 678 citationsRCR 30.5
- 464 citationsRCR 20.1
- Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.J Clin Oncol · 2009442 citationsRCR 12.1
- 407 citationsRCR 19.3
- 388 citationsRCR 13.0
- Oxygen saturation and outcomes in preterm infants.N Engl J Med · 2013375 citationsRCR 16.1